menu
    • menu

    Company profile for Crescita Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Crescita (TSX:CTX) is a publicly traded, Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the s...
    Crescita (TSX:CTX) is a publicly traded, Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin. Crescita owns a portfolio of non-prescription skincare products and has one FDA approved prescription product. Crescita owns the sales and marketing rights in Canada and Mexico

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Crescita TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    2805 Place Louis-R Renaud Laval, Québec, H7V 0A3
    Telephone
    Telephone
    (905) 673-4295
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.crescitatherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/crescita-therapeutics-inc./
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Crescita Reports Third Quarter 2025 Results
    Crescita Reports Third Quarter 2025 Results

    05 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251105811549/en/Crescita-Reports-Third-Quarter-2025-Results

    BUSINESS WIRE
    05 Nov 2025
    Share Share
    Crescita Announces Q2 2025 Results
    Crescita Announces Q2 2025 Results

    06 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250806208573/en/Crescita-Reports-Second-Quarter-2025-Results

    BUSINESSWIRE
    06 Aug 2025
    Share Share
    Crescita Therapeutics Announces Annual Meeting Results
    Crescita Therapeutics Announces Annual Meeting Results

    05 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250605776909/en/Crescita-Therapeutics-Announces-the-Results-of-its-Annual-General-and-Special-Meeting-of-Shareholders

    BUSINESSWIRE
    05 Jun 2025
    Share Share
    Crescita Therapeutics Terminate Licensing Agreement for Pliaglis
    Crescita Therapeutics Terminate Licensing Agreement for Pliaglis

    23 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250523790577/en/Crescita-Therapeutics-Announces-Mutual-Termination-of-Licensing-Agreement-with-Croma-Pharma-GmbH-for-Pliaglis

    BUSINESSWIRE
    23 May 2025
    Share Share
    Crescita Reports First Quarter 2025 Results
    Crescita Reports First Quarter 2025 Results

    14 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250514327128/en/Crescita-Reports-First-Quarter-2025-Results

    BUSINESSWIRE
    14 May 2025
    Share Share
    Crescita Reports Q4 And Fiscal 2024 Results
    Crescita Reports Q4 And Fiscal 2024 Results

    18 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250318209983/en/Crescita-Reports-Q4-and-Fiscal-2024-Results

    BUSINESSWIRE
    18 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search